Research and development of traditional Chinese medicine for cancer

At the annual meeting of Beijing Pharmaceutical Society held on December 21, experts of traditional Chinese medicine pointed out that there were 107 new Chinese medicine drugs approved for marketing after the founding of the people's Republic of China for the treatment of tumors The treatment of tumors by traditional Chinese medicine has attracted extensive attention of the international community, and international research cooperation projects have gradually increased Professor Lin Hongsheng, director of the oncology department of Guang'anmen Hospital, Chinese Academy of traditional Chinese medicine, said in the analysis of the research progress of traditional Chinese medicine for cancer treatment, 107 new Chinese medicine drugs for cancer treatment have been approved by the state drug regulatory authority, most of which are oral Chinese medicine compound preparations, 15 Chinese medicine injections, 6 external preparations, and a small number of ethnic medicine These traditional Chinese medicines have their own clinical emphases, some of which take tumor reduction as the main index, symptom improvement, quality of life and immune function improvement as the secondary index, some of which are assisted by radiotherapy and chemotherapy, or help patients with advanced tumors to improve their symptoms, improve their quality of life, prolong their survival time and carry out immunotherapy; Some for the complications of cancer patients, treatment of advanced cancer pain, cancer chest, ascites and so on Lin Hongsheng pointed out that the traditional Chinese medicine dosage forms commonly used in the treatment of tumors include traditional Chinese medicine decoction, Chinese patent medicine, Chinese medicine injection, Chinese medicine external use, in combination with acupuncture, massage, qigong treatment and psychological adjustment, through syndrome differentiation and treatment, to prevent the occurrence of tumors for susceptible people, reduce the toxicity and increase the efficiency in the early stage of cancer, prevent the recurrence and metastasis and improve the quality of life in the acute, remission and stable stages Prolonging the survival time has a unique effect At present, the international community is increasingly concerned about the cancer treatment of traditional Chinese medicine, and international scientific research cooperation projects are gradually increasing Lin Hongsheng introduced that Guang'anmen Hospital of the Chinese Academy of traditional Chinese medicine and the National Institutes of health of the United States have carried out "Research on the intervention of traditional Chinese medicine on the regulatory T-cells of tumor bearing bodies" and "international cooperation research on the comprehensive treatment scheme of advanced non-small cell lung cancer with traditional Chinese medicine" Fudan University in Shanghai and the National Institutes of health of the United States have carried out "clinical research on the treatment of malignant tumors with Cinobufacin", Longhua Hospital Affiliated to Shanghai University of traditional Chinese medicine and Sloan Catherine cancer research center of the United States carried out the "clinical study on the effect of Jinfukang on nssls", and the Chinese Academy of traditional Chinese medicine and Norway carried out the "international multicenter demonstration study on the comprehensive treatment scheme of traditional Chinese medicine to improve the postoperative radical cure rate of colon cancer" The research and development of traditional Chinese medicine for cancer has become a hot research topic in the world At the meeting, the 2013 outstanding Thesis Award and outstanding pharmacist award were announced, 43 of which were awarded, including 8 Chinese medicine research papers; 10 people won the star award of clinical pharmacist, 30 people won the star award of pharmaceutical care Feng Guoan, President of Beijing Pharmaceutical Association, fan Daiming, academician of Chinese Academy of engineering, etc attended.